Rezulin (REZ-u-lin, troglitazone), for Type II diabetes
January 1997
The FDA is getting close to approving Rezulin (REZ-u-lin, troglitazone), for Type II diabetes.
It'll be the first drug in a new class of meds for diabetes.
Troglitazone helps reduce insulin resistance...an underlying metabolic defect in most patients with Type II diabetes.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote